Pendium

Step 1 of 9

La Roche-Posay owns the 'dermatologist recommended' conversation in AI answers.

The brand's signal is dominant across all major assistants, with the focus now shifting toward defending the lead against aggressive DTC clinical competitors.

La Roche-Posay's baseline score
86/100
Excellent

La Roche-Posay is a dominant force in AI discovery, benefiting from decades of clinical citations and a massive digital footprint. While it holds the 'safe default' position for sensitive skin, there is room to tighten the narrative around its newest high-science molecules.

What we see
  • La Roche-Posay maintains an exceptionally high visibility score due to pervasive mentions in professional dermatological literature and consumer review sites.
  • ChatGPT and Claude view the brand as a 'safe' recommendation, often placing it first or second in lists for sensitive skin.
  • Gemini identifies strong YouTube and Reddit creator signals, particularly for the Anthelios and Cicaplast lines.
  • AI Overviews pull directly from the brand's highly-optimized product pages and major e-commerce retailers like Amazon and Ulta.
  • The Mela B3 launch has already achieved significant AI visibility, showing the brand's ability to quickly seed new ingredient stories.
Business goals La Roche-Posay is likely trying to hit
  • Maintain dominance in the dermatologist-recommended sunscreen category
  • Drive adoption of high-margin anti-aging serums like Mela B3 and Hyalu B5
  • Capture market share in the sensitive-skin body care segment from CeraVe
  • Expand authority in the post-procedure and skin-barrier repair niche